All Type of News


9 of 24 new drugs approved last year was antibiotic neoplastic agent

It was observed there were 24 pharmaceutical products approved as new drug in Korea, and 9 of them were anticancer drugs. In the recently-published ‘2016 Drug Approval Report,’ the Ministry of Food and Drug Safety an...

Janssen files patent infringement trial against Samsung Bioepis

Janssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis. Janssen recently sued Samsung Bioepis for infringing the 3 patents of ...

MFDS designates products similar to teeth whitening as quasi drug

Products that are similar to teeth whitening kits will be controlled by being designated by the government as quasi drug. The Ministry of Food and Drug Safety(MFDS) made a partial revision to the ‘Notification of the...

“The government must control illegal sales of OTC medicines at supermarkets and local stores”

The Korean Pharmaceutical Association(Chairman Chan-Hwi Cho, KPA) released an written statement to take term measures against illegal sales of pharmaceutical products at supermarkets and local stores. A number of sup...

GreenCross MS supplies hemodialysis solutions of KRW 90 billion to Boryung Pharm

GreenCross Medical Science(CEO Young-Pil Kim, GreenCross MS) announced on the 19th it signed a long-term supply agreement of supplying hemodialysis solutions for 10 years with Boryung Pharm(CEO Tae-Hong Choi). GreenC...

Pharma industry will take lead in ‘Job Creation,’ key assignment of the new administration

As ‘Job Creation,’ one of the main promises made by President Jae-In Moon of Korea, intersects with the pharmaceutical industry’s ability of creating jobs, it has been highly expected that the government would be more...

24 incrementally modified drugs newly approved last year, increased by 33%

The number of incrementally modified drugs approved last year was the total 24 products, increased by 33% compared to the year of 2015. The Ministry of Food and Drug Safety revealed that 24 products were approved as ...

Female CEOs’ ‘Outstanding performance’ in management, marketing and R&D at listed pharmas

Although the female executive ratio is only 7% in listed pharmaceutical companies, they are evaluated to have outstanding performance with their active activities. According to the Yakup Shinmoon’s(www.yakup.com) ana...

Celltrion’s active launching process for Truxima, starting to sell in Germany

Celltrion announced on the 18th that it has started to prepare for an official launch of ‘Truxima,’ the first antibody biosimilar for the treatment of blood cancer, even in Germ...

Bukwang Pharm acquires joint license of Meditoxin Inj for treatment purpose from Eisai

Bukwang Pharm announced that it signed a co-marketing and distribution agreement with Eisai Korea for the co-sales and exclusive distribution license of ‘Meditoxin Inj 200 Units...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.